Latest / Matt Brown Show - Conversations That Power The Business World.
MBS498 - How to solve endometriosis problems for 190 million women - Somer Baburek, CEO Herabiotech (Built in Texas #3)
Send us Fan Mail
Hera began operations in January of 2020 as a Delaware “C” Corporation with headquarters in San Antonio, TX. Hera’s initial goal is to commercialize the MetriDx™, a novel, non-surgical method for the definitive and early diagnosis of endometriosis. Endometriosis is defined as the presence of endometrial glands and stromal-like lesions outside of the uterus.
Endometriosis affects 10-20% of all women of reproductive age; 7-13 million in the US alone. Current diagnosis of endometriosis is by visualization during laparoscopic surgery, confirmed by histological pathology…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.